Auxly Cannabis Group Inc.
TSX:XLY.TODrug Manufacturers - Specialty & Generic
+$0.00 today
- Market cap
- $364.42M
- Beta
- 1.16
- P/E (TTM)
- 7.3
- EPS (TTM)
- $0.02
Volume 0.13M
Average 0.71M
XLY.TO Stock-Based Compensation
Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.
Auxly Cannabis Group Inc.TSX: XLY.TO
Stock-Based Compensation · Q1 FY2026 · quarter ended Mar 2026
Stock-based compensation dips below year-ago levels
Q1 FY2026 stock-based compensation of CA$1.01M fell 31.0% year over year, behind the +5.0% change in trailing-twelve-month stock-based compensation. Sequentially, it fell 31.6% from the prior quarter. Over 3 fiscal years it compounded at +9.4% a year.
Context
- Stock-based compensation amounted to 3.5% of revenue in FY2025, down 0.6 pp from a year earlier.
- Stock-based compensation increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -31.0% toward the trailing-twelve-month pace of +5.0%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Stock-Based Compensation history
CAD · from the cash flow
- Latest · FY2025
- 5.27M CAD
- Year-over-year change
- +4.4%
- 4-year CAGR
- +38.4%
| Period | Period end | Stock-Based Compensation | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 5.27M | +4.4% |
| FY2024 | 2024-12-31 | 5.05M | +207.4% |
| FY2023 | 2023-12-31 | 1.64M | -59.2% |
| FY2022 | 2022-12-31 | 4.02M | +180.7% |
| FY2021 | 2021-12-31 | 1.43M | — |
Stock-Based Compensation vs competitors
How XLY.TO compares with its peers on the latest reported figures
- Peers report in different currencies, so stock-based compensation is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +5.0% is the highest of 4, against a peer median of -30.3%.
- Stock-based compensation amounts to 3.0% of revenue for XLY.TO, versus a peer median of 1.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | CA$11.4M CAD | -21.5% | +28.8% | — | |
| LTM Mar 2026 | CA$4.81M CAD | +5.0% | +9.4% | 3.0% | |
| LTM Mar 2026 | CA$2.25M CAD | -37.4% | -15.9% | 0.6% | |
| LTM Mar 2026 | $1.4M USD | -30.3% | -13.2% | 2.5% | |
| Peer median (excluding XLY.TO) | — | -30.3% | -13.2% | 1.6% | |
Competitors are the stored peer set for XLY.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (45.91M) | (130.29M) | (44.51M) | (16.35M) | 41.86M |
| Depreciation & Amortization | 14.27M | 21.58M | 11.21M | 10.28M | 11.45M |
| Deferred Income Tax | (4.33M) | (6.26M) | (3.24M) | 15.99M | (9.34M) |
| Stock-Based Compensation | 1.43M | 4.02M | 1.64M | 5.05M | 5.27M |
| Change in Working Capital | (29.66M) | 20.04M | 17.87M | (54K) | (12.68M) |
| Accounts Receivables | (16.65M) | 10.41M | 801K | (5.83M) | 134K |
| Inventory | (6.93M) | (3.22M) | 12.72M | 1.57M | (3.25M) |
| Accounts Payables | 210K | 3.17M | 7.16M | 3.69M | (9.05M) |
| Other Working Capital | (6.28M) | 9.69M | (2.81M) | 515K | (515K) |
| Other Non-Cash Items | 14.56M | 88.43M | 25.25M | 1.87M | (10.67M) |
| Operating Cash Flow | (49.63M) | (2.48M) | 8.21M | 16.78M | 25.89M |
| Capital Expenditures | (378K) | (9.19M) | (1.6M) | (2.76M) | (2.52M) |
| Acquisitions (Net) | 7.47M | 10.3M | 0 | 0 | 54K |
| Purchases of Investments | (900K) | (10.37M) | 0 | 0 | 0 |
| Sales of Investments | 10.24M | 71K | 0 | 100K | 0 |
| Other Investing Activities | 897K | 10.37M | 47K | 2.22M | 0 |
| Investing Cash Flow | 17.33M | 1.18M | (1.56M) | (445K) | (2.46M) |
| Debt Repayment | 29.71M | (6.76M) | (8.39M) | (14.48M) | (8.36M) |
| Common Stock Issued | 44.94M | 7.94M | 3.13M | 1.5M | 976K |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (4.39M) | 7.94M | (431K) | (612K) | (2.42M) |
| Financing Cash Flow | 26.4M | 1.18M | (5.69M) | (13.59M) | (9.81M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (5.9M) | (118K) | 972K | 2.75M | 13.62M |
| Free Cash Flow | (50.01M) | (11.67M) | 6.61M | 14.02M | 23.37M |
Auxly Cannabis Group Inc.
TSX:XLY.TO
Intrinsic Alpha fair value
Locked
Current Price
$3.53
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.